CClinicalTrials.gg
CompletedNCT04191772EXIMSUpdated Aug 31, 2021

The Impact of Training on Sitting Time and Brain Volumes in Multiple Sclerosis.

An interventional study of Periodized, home-based running program in Multiple Sclerosis, sponsored by Hasselt University. Completed at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-31.

Sponsored by Hasselt University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
156
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The current study aims to investigate whether persons with Multiple Sclerosis (PwMS) compensate training time with more sedentary time and consequently blunt training effects. The second aim will be to investigate the effect of a structured training program on specific brain volumes and cognitive variables.

Read the detailed description

Multiple Sclerosis is a progressive, autoimmune, neurodegenerative disorder of the central nervous system (CNS) that predominantly affects young to middle-aged adults. It is characterized by a chronic inflammatory process that causes demyelination, axonal damage and white matter lesions across the CNS. Furthermore, evidence also indicates grey matter (GM) atrophy which has been reported to be significantly correlated with both clinical and cognitive deterioration. Clinical manifestations include spasticity, tremor, paralysis, walking difficulties and cognitive abnormalities. Due to these primary disease symptoms, persons with MS (PwMS) appear to be susceptible to a sedentary lifestyle and inactivity, which consequently increases the risk of other important, health-related secondary deficits including respiratory, metabolic and cardiac dysfunction. These deficits further contribute to a decrease in cardiorespiratory fitness and quality of life (QoL), thereby causing a vicious circle of decreased exercise tolerance, greater disability and increased inactivity. Since pharmacological treatment has little impact on these secondary deficits, exercise therapy has become an important aspect of the treatment of MS.

Hence, exercise therapy interventions in MS have been studied extensively and have already been proven to significantly improve cardiorespiratory fitness, muscle strength, balance, fatigue, cognition, quality of life, respiratory function and brain volumes. Moreover, a dose-response relationship has been reported for functional variables such as strength and endurance capacity. As such, high intensity interval training (HIIT) probably is exerts superior effects compared to traditional low/moderate intensity continuous training (MICT). However and in contrast with other populations, effects of HIIT on important health-related variables such as body composition, blood pressure and blood lipid profiles are less evident. Possibly, PwMS do not reach the exercise intensities required to improve such factors due to cardiovascular autonomic dysfunction, leading to impaired carotid baroreflex control, attenuated elevations in blood pressure and disturbed increases in heart rate, and abnormal muscle energy metabolism. Moreover, higher intensities might hamper longer-term implementation in real life, as an inverse relation between exercise intensity and training adherence has already been reported.

Training periodization (alternating HIIT and MICT) offers a solution to overcome the barrier of adherence and concurrently augmenting training effects, but in contrast to other populations, the addition of a lower intensity training component does still not improve health-related variables. Therefore, other approaches are warranted. Recently, evidence is growing that sedentary time is an important health risk factor, independent of the (dis)practice of structured exercise. Hence, PwMS possibly compensate training effects with even more sedentary time, in addition to an already sedentary lifestyle as mentioned previously. As such, addressing sedentary time might be an interesting new approach to counteract the health-related deficits in PwMS. Therefore, the present study explores the impact of a structured exercise program on sedentary time and health-related variables.

Furthermore, a secondary aim of the current project is to investigate the effect of a periodized training program on brain volumes and cognitive function. Recent evidence of physical training effects on cognitive variables is contradictory. So for exercise intervention studies that studied the latter only used short-term and laboratory-based training programs and included exercise modalities (type, intensity, duration) that are difficult to compare. Interestingly, a recent short-term randomized controlled trial reported superior effects of HIIT on cognitive functions compared to MICT. Hence, the current study aims to investigate the impact of a long-term, home-based training program with HIIT-components on cognitive variables.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • Sedentary time
  • Exercise
  • Brain volume
  • Health-related variables
  • Immunological variables
  • Multiple Sclerosis
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 156 is above the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Hasselt University is the lead sponsor of 195 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Multiple Sclerosis according to the McDonald criteria (Relaps remitting)
  • Written informed consent
  • Medical safety screening

Exclusion criteria

Exclusion Criteria:

  • Contra-indications to participate in moderate to high intensity exercise
  • Contra-indications to undergo magnetic resonance imaging (pacemaker/defibrillator or wires other than sternal wires, insulin pumps, metal foreign bodies, deep brain stimulator, cerebral aneurysm clips, cochlear implant, magnetic dental implant, drug infusion device)
  • Medication changes in the last month before the start of the intervention
  • Following or plan to follow a weight reduction program
  • Pregnancy
  • Participation in another study
  • Acute MS exacerbation \< 3 months prior to the start of the study
  • EDSS score > 4
  • Consumption of more than 20 alcohol units/week
  • No daily internet access
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
156 participants (actual)

Study arms

  • Experimental
    MS - training goal 1

    Persons with Multiple Sclerosis (PwMS) with a 'poor VO2max', a 'fair VO2max' with no running experience and a 'good VO2max' with no running experience (VO2max values according to V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics) will receive an exercise intervention existing of home-based running sessions. Participants of the first training group will be trained to run continuously for 45 minutes.

    Other: Periodized, home-based running program

  • Experimental
    HC - training goal 1

    Healthy control (HC) persons with a 'poor VO2max', a 'fair VO2max' with no running experience and a 'good VO2max' with no running experience (VO2max values according to V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics) will receive an exercise intervention existing of home-based running sessions. Participants of the first training group will be trained to run continuously for 45 minutes.

    Other: Periodized, home-based running program

  • Experimental
    MS - training goal 2

    PwMS with a 'fair VO2max' and running experience, a 'good VO2max and running experience', an 'excellent VO2max' and a 'superior VO2max' (VO2max values according to V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics) will receive an exercise intervention existing of home-based running sessions. Participants of the second training group will be trained to run continuously for 75 minutes.

    Other: Periodized, home-based running program

  • Experimental
    HC - training goal 2

    HC with a 'fair VO2max' and running experience, a 'good VO2max and running experience', an 'excellent VO2max' and a 'superior VO2max' (VO2max values according to V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics) will receive an exercise intervention existing of home-based running sessions. Participants of the second training group will be trained to run continuously for 75 minutes.

    Other: Periodized, home-based running program

  • No intervention
    MS - sedentary control group

    Twenty PwMS will receive no intervention, only usual care.

  • No intervention
    HC - sedentary control group

    Twenty HC will receive no intervention, only usual care.

Interventions

  • OtherPeriodized, home-based running program

    All participants will perform a home-based supervised exercise training program. Participants will receive weekly training instructions using a smartphone-based heart rate monitor application (Polar® app). Training sessions will involve running and the design of the training program will be based on linear periodization, where aerobic capacity is built firstly through a period of high-volume/low-intensity training before the proportion of high-intensity training is increased. The total duration of the exercise program will be 12 months with three weekly training sessions. Training progression will be dependent on initial VO2max values and running experience. VO2max classification is based on reference values described in V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics.

06

What researchers measure

Primary outcomes

  1. Number of steps per day

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Before start of the training program

  2. Number of steps per day

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 1 of the training program

  3. Number of steps per day

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 24 of the training program

  4. Number of steps per day

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 48 of the training program

  5. Number of steps per day

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: 3 months after the training program

  6. Sitting time

    Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Before start of the training program

  7. Sitting time

    Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 1 of the training program

  8. Sitting time

    Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 24 of the training program

  9. Sitting time

    Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 48 of the training program

  10. Sitting time

    Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: 3 months after the training program

  11. Standing time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Before start of the training program

  12. Standing time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 1 of the training program

  13. Standing time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 24 of the training program

  14. Standing time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 48 of the training program

  15. Standing time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: 3 months after the training program

  16. Stepping time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Before start of the training program

  17. Stepping time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 1 of the training program

  18. Stepping time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 24 of the training program

  19. Stepping time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: Week 48 of the training program

  20. Stepping time

    Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK).

    Time frame: 3 months after the training program

Secondary outcomes

  1. Blood pressure

    Systolic, diastolic and mean arterial blood pressure will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements.

    Time frame: Baseline

  2. Blood pressure

    Systolic, diastolic and mean arterial blood pressure will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements.

    Time frame: Week 48 of the training program

  3. Resting heart rate

    Resting heart rate will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements.

    Time frame: Baseline

  4. Resting heart rate

    Resting heart rate will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements.

    Time frame: Week 48 of the training program

  5. Total calorie intake

    Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.

    Time frame: Baseline

  6. Total calorie intake

    Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.

    Time frame: Week 12 of the training program

  7. Total calorie intake

    Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.

    Time frame: Week 24 of the training program

  8. Total calorie intake

    Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.

    Time frame: Week 48 of the training program

  9. Total calorie intake

    Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated.

    Time frame: 3 months after the training program

  10. Macronutrient content

    Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.

    Time frame: Baseline

  11. Macronutrient content

    Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.

    Time frame: Week 12 of the training program

  12. Macronutrient content

    Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.

    Time frame: Week 24 of the training program

  13. Macronutrient content

    Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.

    Time frame: Week 48 of the training program

  14. Macronutrient content

    Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated.

    Time frame: 3 months after the training program

  15. Participation - Ghent Participation Scale (GPS)

    The GPS is a generic instrument including both objective and all relevant subjective variables resulting in one score, already proven to be valid to rate participation in MS.

    Time frame: Baseline

  16. Participation - Ghent Participation Scale (GPS)

    The GPS is a generic instrument including both objective and all relevant subjective variables resulting in one score, already proven to be valid to rate participation in MS.

    Time frame: Week 48 of the training program

  17. Mobility - MS walking scale (MSWS-12)

    The MSWS-12 is a 12-item self-assessment scale which measures the impact of MS on mobility, which showed the ability of a running program to reduce impact of MS on walking ability in a previous pilot RCT by our research group

    Time frame: Baseline

  18. Mobility - MS walking scale (MSWS-12)

    The MSWS-12 is a 12-item self-assessment scale which measures the impact of MS on mobility, which showed the ability of a running program to reduce impact of MS on walking ability in a previous pilot RCT by our research group

    Time frame: Week 48 of the training program

  19. Fatigue - Modified Fatigue Impact scale (MFIS)

    To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.

    Time frame: Before start of the intervention

  20. Fatigue - Modified Fatigue Impact scale (MFIS)

    To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.

    Time frame: Week 1 of the intervention

  21. Fatigue - Modified Fatigue Impact scale (MFIS)

    To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.

    Time frame: Week 12 of the training program

  22. Fatigue - Modified Fatigue Impact scale (MFIS)

    To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.

    Time frame: Week 24 of the training program

  23. Fatigue - Modified Fatigue Impact scale (MFIS)

    To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.

    Time frame: Week 48 of the training program

  24. Fatigue - Modified Fatigue Impact scale (MFIS)

    To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed.

    Time frame: 3 months after the training program

  25. Cognition - Spatial Recall test (SPART)

    The SPART is a visuospatial learning and delayed recall test, where a checkerboard with seven checkers in specified places is presented for 10sec to the participants who have to place the checkers back on a blank checkerboard immediately after and after another 30min. The total score is a sum of the correct checkers. This has been shown to be one of the most sensitive measures for detecting memory impairments in PwMS and showed improved performance after a running program in a previous pilot RCT of our research group

    Time frame: Baseline

  26. Cognition - Spatial Recall test (SPART)

    The SPART is a visuospatial learning and delayed recall test, where a checkerboard with seven checkers in specified places is presented for 10sec to the participants who have to place the checkers back on a blank checkerboard immediately after and after another 30min. The total score is a sum of the correct checkers. This has been shown to be one of the most sensitive measures for detecting memory impairments in PwMS and showed improved performance after a running program in a previous pilot RCT of our research group

    Time frame: Week 48 of the training program

  27. Cognition - Symbol Digit Modalities Test (SDMT)

    The SDMT is a test of information processing speed (PS) in which participants need to combine as many symbols with the accompanying numbers as possible in 90 seconds. The SDMT has been found to be a reliable and valid test in MS and a responder definition of approximating 4 points or 10% in magnitude SDMT change was recommended.

    Time frame: Baseline

  28. Cognition - Symbol Digit Modalities Test (SDMT)

    The SDMT is a test of information processing speed (PS) in which participants need to combine as many symbols with the accompanying numbers as possible in 90 seconds. The SDMT has been found to be a reliable and valid test in MS and a responder definition of approximating 4 points or 10% in magnitude SDMT change was recommended.

    Time frame: Week 48 of the training program

  29. Body weight

    Body weight is determined using a digital-balanced weighting scale to the nearest 0.1kg

    Time frame: Baseline

  30. Body weight

    Body weight is determined using a digital-balanced weighting scale to the nearest 0.1kg

    Time frame: Week 48 of the training program

  31. Height

    Body height is measured to the nearest 0.1cm using a wall-mounted Harpenden stadiometer, with participants barefoot

    Time frame: Baseline

  32. Height

    Body height is measured to the nearest 0.1cm using a wall-mounted Harpenden stadiometer, with participants barefoot

    Time frame: Week 48 of the training program

  33. DEXA (Dual Energy X-Ray)

    body fat mass and lean tissue mass using Dual Energy X-ray Absorptiometry

    Time frame: Baseline

  34. DEXA (Dual Energy X-Ray)

    body fat mass and lean tissue mass using Dual Energy X-ray Absorptiometry

    Time frame: Week 48 of the training program

  35. Coordination - timed tandem walk (TTW)

    Participants will have to walk in a straight line with one foot immediately in front of the other (heel to toe), while the arms are kept down at the side. Time to complete 3 meter will be monitored.

    Time frame: Baseline

  36. Coordination - timed tandem walk (TTW)

    Participants will have to walk in a straight line with one foot immediately in front of the other (heel to toe), while the arms are kept down at the side. Time to complete 3 meter will be monitored.

    Time frame: Week 48 of the training program

  37. Oxygen uptake (VO2)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VO2 is collected breath-by-breath and averaged every ten seconds.

    Time frame: Baseline

  38. Oxygen uptake (VO2)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VO2 is collected breath-by-breath and averaged every ten seconds.

    Time frame: Week 48 of the training program

  39. Carbon dioxide output (VCO2)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VCO2 is collected breath-by-breath and averaged every ten seconds.

    Time frame: Baseline

  40. Carbon dioxide output (VCO2)

    Cardiopulmonary exercise test on on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VCO2 is collected breath-by-breath and averaged every ten seconds.

    Time frame: Week 48 of the training protocol

  41. Minute ventilation (VE)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE is collected breath-by-breath and averaged every ten seconds.

    Time frame: Baseline

  42. Minute ventilation (VE)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE is collected breath-by-breath and averaged every ten seconds.

    Time frame: Week 48 of the training protocol

  43. Equivalents for oxygen uptake (VE/VO2)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VO2 is collected breath-by-breath and averaged every ten seconds.

    Time frame: Baseline

  44. Equivalents for oxygen uptake (VE/VO2)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VO2 is collected breath-by-breath and averaged every ten seconds.

    Time frame: Week 48 of the training protocol

  45. Equivalents for carbon dioxide production (VE/VCO2)

    Cardiopulmonary exercise test on on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VCO2 is collected breath-by-breath and averaged every ten seconds.

    Time frame: Baseline

  46. Equivalents for carbon dioxide production (VE/VCO2)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VCO2 is collected breath-by-breath and averaged every ten seconds.

    Time frame: Week 48 of the training program

  47. Tidal volume (Vt)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis Vt is collected breath-by-breath and averaged every ten seconds.

    Time frame: Baseline

  48. Tidal volume (Vt)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis Vt is collected breath-by-breath and averaged every ten seconds.

    Time frame: Week 48 of the training program

  49. Breathing frequency (BF)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis BF is collected breath-by-breath and averaged every ten seconds.

    Time frame: Baseline

  50. Breathing frequency (BF)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis BF is collected breath-by-breath and averaged every ten seconds.

    Time frame: Week 48 of the training protocol

  51. Respiratory gas exchange ratio (RER)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis RER is collected breath-by-breath and averaged every ten seconds.

    Time frame: Baseline

  52. Respiratory gas exchange ratio (RER)

    Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis RER is collected breath-by-breath and averaged every ten seconds.

    Time frame: Week 48 of the training program

  53. Cardiorespiratory fitness (CRF)

    CRF will be measured with a maximal cardiopulmonary exercise test on a bicycle ergometer.

    Time frame: Baseline

  54. Cardiorespiratory fitness (CRF)

    CRF will be measured with a maximal cardiopulmonary exercise test on a bicycle ergometer.

    Time frame: Week 48 of the training program

  55. Lipidomic profile

    Blood analysis

    Time frame: Baseline

  56. Lipidomic profile

    Blood analysis

    Time frame: Week 48 of the training program

  57. Brain volumes

    MRI scan

    Time frame: Baseline

  58. Brain volumes

    MRI scan

    Time frame: Week 48 of the training program

  59. PBMC subset parameters

    flow cytometry analysis of immune cell subsets in peripheral blood-derived mononuclear cells (PBMCs)

    Time frame: Baseline

  60. PBMC subset parameters

    flow cytometry analysis of immune cell subsets in peripheral blood-derived mononuclear cells (PBMCs)

    Time frame: Week 48 of the training program

  61. serum cytokines

    cytokine levels are measured by ELISA on serum derived from peripheral blood samples

    Time frame: Baseline

  62. serum cytokines

    cytokine levels are measured by ELISA on serum derived from peripheral blood samples

    Time frame: Week 48 of the training program

07

Study locations

1 site
  • Hasselt University
    Diepenbeek, Limburg 3590, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04191772
Lead sponsor
Hasselt University
Responsible party
Bert Op't Eijnde (Principal Investigator, Hasselt University) — Principal investigator
First posted
Dec 10, 2019
Start date
Jan 15, 2020
Primary completion
Jun 30, 2021
Completion
Jun 30, 2021
Last update
Aug 31, 2021

Study contacts

Bert Op 't Eijnde, Prof. dr.
study chair · Hasselt University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion